Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating
Multicentric Study of the Autologous Bone Marrow-derived Mononuclear Cells Injection for Treatment of the Patients With Critical Lower Extremity Ischemia
Sponsor: Fundação Araucária
This PHASE1/PHASE2 trial investigates Diabetic Foot and Gangrene and is currently ongoing. Fundação Araucária leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
▶ Show 2 earlier versions
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Unknown Status → Active Not Recruiting
-
Jan 2017 — Dec 2017 [monthly]
Unknown Status PHASE1_PHASE2
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundação Araucária
- Hospital Geral Nacional Enrique Cabrera, Cuba
- Hospital Sao Rafael
- Instituto de Hematología e Inmunología, Cuba
- Instituto de Moléstias Cardiovasculares de São José do Rio Preto, Brazil
- Pontifícia Universidade Católica do Paraná
For direct contact, visit the study record on ClinicalTrials.gov .